[Form 4] Albemarle Corporation Insider Trading Activity

Rhea-AI Filing Summary

Albemarle Corporation (ALB) – Form 4 insider filing dated 07/03/2025

Non-employee director Ralf Hans Cramer reported routine equity transactions related to the company’s 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors:

• Grant of 2,725 common shares on 07/01/2025 as the director’s annual equity retainer; the shares vest on 07/01/2026.
• Tax withholding: 602 previously granted shares were forfeited at an imputed price of $62.90 to satisfy tax obligations upon vesting of the 07/01/2024 award.
• Dividend equivalents: 37 additional shares were issued in lieu of cash dividends on the 2024 award; 13 of those shares were simultaneously withheld at the same $62.90 price to cover related taxes.

After the transactions, the director’s direct beneficial ownership totals 5,379 ALB shares. No derivative securities were reported.

The filing is administrative and compensation-related; it does not disclose any open-market purchases or sales that would typically signal a directional view on the stock. The dollar value of shares involved is modest relative to Albemarle’s market capitalization and daily volume, and therefore the transaction is unlikely to be material for investors.

Insights

Securities Analyst

TL;DR: Routine director equity grant and tax-withholding; neutral impact on Albemarle share outlook.

The Form 4 documents standard annual stock compensation for director Ralf Hans Cramer. The 2,725-share grant is scheduled to vest in 12 months, encouraging board alignment with shareholders but not altering near-term float because shares are already reserved under the 2023 Directors Plan. Shares withheld (602 + 13) merely fund tax liabilities and do not represent market sales. Net ownership of 5,379 shares suggests continued exposure but the stake is small (≈0.004% of diluted shares). No options, warrants, or derivative conversions were disclosed. Given the modest size and non-cash nature, this event does not affect earnings, liquidity, or strategic direction. I classify the disclosure as neutral, non-impactful for investment theses.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cramer Ralf Hans

(Last) (First) (Middle)

ALBEMARLE CORPORATION

4250 CONGRESS ST., STE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		A		2,725(1)	A	$0	5,957	D
Common Stock	07/01/2025		F		602(2)	D	$62.9	5,355	D
Common Stock	07/01/2025		A		37(3)	A	$0	5,392	D
Common Stock	07/01/2025		F		13(4)	D	$62.9	5,379	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares represent an annual award of non-employee director stock compensation issued under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2026.

2. Shares reported were withheld to meet tax liabilities associated with vesting of a grant originally made on July 1, 2024.

3. Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock issued under the 2023 Directors Plan.

4. Shares reported were withheld to meet tax liabilities associated with vesting of dividends accrued on a grant originally made on July 1, 2024.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Rebekah Richards, Attorney-in-Fact	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Albemarle (ALB) shares did director Ralf Cramer receive on 07/01/2025?

He received 2,725 shares as part of the annual non-employee director equity award.

What is the vesting schedule for the newly granted ALB shares?

The shares granted on 07/01/2025 vest on 07/01/2026.

Why were 602 Albemarle shares disposed of in the Form 4?

The 602 shares were automatically withheld for tax obligations arising from a prior award’s vesting.

What is the director’s total ALB share ownership after the reported transactions?

Following the transactions, Ralf Hans Cramer directly owns 5,379 common shares of Albemarle.

Did the Form 4 report any open-market purchases or sales?

No. All transactions were equity grants or tax-withholding dispositions; no market trades occurred.